Convergence in GI: Dr. Erica Barnell on AI, Biology & the Future of Diagnostics скачать в хорошем качестве

Convergence in GI: Dr. Erica Barnell on AI, Biology & the Future of Diagnostics

What happens when you combine a decade of science, a powerful entrepreneurial story, and two exponential waves—AI and digital biology? You get Geneoscopy. On the latest episode of The Scope Forward Show, I caught up with Dr. Erica Barnell—Co-founder and Chief Science Officer of Geneoscopy. If you don’t know Erica yet, you should. She and her team just raised $112 million in a tough VC environment. Their lead assay, ColoSense, is now the first FDA-approved, RNA-based, non-invasive diagnostic test for colorectal cancer and advanced adenomas. But this conversation went far beyond funding and FDA milestones. We talked about: 08:44 - What’s next in IBD precision diagnostics and biomarker innovation 11:54 - How AI has replaced costly bioinformatics layers and transformed their R&D 15:34 - Why AI is not “artificial” at all—and how to use it without fear 18:37 - How patients are being guided through diagnostics via smart automation (text, email, even Uber Health) 26:39 - Why GI, like OB/GYN, is primed for disruption This wasn’t just a company update—it was a glimpse into the future of our entire field. We’re in a convergence era. Biology is becoming programmable. Intelligence is being digitized. And GI—if we lean in—has a front-row seat to reinvent itself. #digitalhealth #gastroenterology #thescopeforwardshow #nextservices #gi #future #ai #theshift